Michael C. Keefer

5.4k citations

71 papers · 2.2k indexed · h-index 31

Impact in

Virology top 0.5%
- HIV Research and Treatment
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in ⓘ

Virology 49
- HIV Research and Treatment 46
Immunology 33
- Immune Cell Function and Interaction 21
- Immunotherapy and Immune Responses 12
- T-cell and B-cell Immunology 8

Co-authors: David C. Montefiori (15 shared papers)Kent J. Weinhold (13 shared papers)Barney S. Graham (13 shared papers)Lawrence Corey (15 shared papers)M. Juliana McElrath (15 shared papers)Geoffrey J. Gorse (10 shared papers)Mark J. Mulligan (9 shared papers)Thomas G. Evans (6 shared papers)
Journals: Vaccine (12 papers)The Journal of Infectious Diseases (9 papers)PLoS ONE (8 papers)AIDS Research and Human Retroviruses (4 papers)Clinical Infectious Diseases (3 papers)
Partner nations: United States South Africa France

In The Last Decade

Michael C. Keefer

70 papers receiving 2.1k citations

Peers

Countries citing papers authored by Michael C. Keefer

Since Specialization

Citations

This map shows the geographic impact of Michael C. Keefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Keefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Keefer more than expected).

Fields of papers citing papers by Michael C. Keefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Keefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Keefer. The network helps show where Michael C. Keefer may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael C. Keefer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael C. Keefer Line = papers co-authored together Michael C. Keefer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers AIDS ·Robert B. Belshe, Geoffrey J. Gorse, Mark J. Mulligan, Thomas G. Evans, Michael C. Keefer, Jean‐Louis Excler, Anne‐Marie Duliège, James Tartaglia, William I. Cox, James McNamara, Kai-Lin Hwang, Alice P. Bradney, David C. Montefiori, Kent J. Weinhold	1998	140
2	A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8⁺Cytotoxic T Lymphocyte Responses in Seronegative Volunteers The Journal of Infectious Diseases ·Thomas G. Evans, Michael C. Keefer, Kent J. Weinhold, Mark Wolff, David C. Montefiori, Geoffrey J. Gorse, Barney S. Graham, M. Juliana McElrath, Mary Lou Clements‐Mann, Mark J. Mulligan, Patricia Fast, Mary Clare Walker, Jean‐Louis Excler, A M Duliege, James Tartaglia, (unknown)	1999	134
3	QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans Vaccine ·Thomas G. Evans, M. Juliana McElrath, Thomas J. Matthews, David C. Montefiori, Kent J. Weinhold, Mark Wolff, Michael C. Keefer, Esper G. Kallás, Lawrence Corey, Geoffrey J. Gorse, Robert B. Belshe, Barney S. Graham, Paul Spearman, David H. Schwartz, Mark J. Mulligan, Paul A. Goepfert, Patricia Fast, P W Berman, Michael F. Powell, Don Francis	2001	106
4	Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A Antiviral Research ·Peter D. Reuman, David I. Bernstein, Michael C. Keefer, Elizabeth C. Young, James Sherwood, Gilbert M. Schiff	1989	71
5	High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination Virology ·Katie L. Davis, Elin S. Gray, Penny L. Moore, Julie M. Decker, Aidy Salomon, David C. Montefiori, Barney S. Graham, Michael C. Keefer, Abraham Pinter, Lynn Morris, Beatrice H. Hahn, George M. Shaw	2009	71
6	Safety and Immunogenicity of a High-Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV-1–Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kalpana Gupta, Michael G. Hudgens, Lawrence Corey, M. Juliana McElrath, Kent J. Weinhold, David C. Montefiori, Geoffrey J. Gorse, Sharon E. Frey, Michael C. Keefer, Thomas G. Evans, Raphael Dolin, David H. Schwartz, Clayton Harro, Barney S. Graham, Paul Spearman, Mark J. Mulligan, Paul A. Goepfert	2002	70
7	Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120 JAIDS Journal of Acquired Immune Deficiency Syndromes ·Nina D. Russell, Barney S. Graham, Michael C. Keefer, M. Juliana McElrath, Steve Self, Kent J. Weinhold, David C. Montefiori, Guido Ferrari, Helen Horton, Georgia D. Tomaras, Sanjay Gurunathan, Lynn Baglyos, Sharon E. Frey, Mark J. Mulligan, Clayton Harro, Susan Buchbinder, Lindsey R. Baden, William A. Blattner, Beryl A. Koblin, Lawrence Corey	2006	69
8	Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines The Journal of Infectious Diseases ·Barney S. Graham, M. Juliana McElrath, Ruth I. Connor, David H. Schwartz, Geoffrey J. Gorse, Michael C. Keefer, Mark J. Mulligan, Thomas J. Matthews, Steven M. Wolinsky, David C. Montefiori, Sten H. Vermund, John S. Lambert, Lawrence Corey, Robert B. Belshe, Raphael Dolin, Peter F. Wright, Bette Korber, Mark Wolff, Patricia Fast, (unknown), (unknown)	1998	62
9	Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine Regimen The Journal of Infectious Diseases ·Lawrence Corey, M. Juliana McElrath, Kent J. Weinhold, Thomas J. Matthews, Donald M. Stablein, Barney S. Graham, Michael C. Keefer, David H. Schwartz, Geoffrey J. Gorse, (unknown)	1998	57
10	Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization Journal of Virology ·Cheng Cheng, Jason G. Gall, Martha Nason, C. Richter King, Richard A. Koup, Mario Roederer, M. Juliana McElrath, Cecilia Morgan, Gavin Churchyard, Lindsey R. Baden, Ann Duerr, Michael C. Keefer, Barney S. Graham, Gary J. Nabel	2009	57
11	Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity PLoS ONE ·Barney S. Graham, M. Juliana McElrath, Michael C. Keefer, Kyle Rybczyk, David Berger, Kent J. Weinhold, Janet Ottinger, Guido Ferarri, David C. Montefiori, Don Stablein, Carol Smith, Richard S. Ginsberg, John H. Eldridge, Ann Duerr, Pat Fast, Barton F. Haynes, (unknown)	2010	56
12	Safety profile of recombinant canarypox HIV vaccines Vaccine ·Guy de Bruyn, Anthony Rossini, Ya-Lin Chiu, Drienna Holman, Marnie Elizaga, Sharon E. Frey, Donald S. Burke, Thomas G. Evans, Lawrence Corey, Michael C. Keefer	2003	53
13	A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody Scientific Reports ·Aitor Nogales, Michael S. Piepenbrink, Jiong Wang, Sandra Ortega, Madhubanti Basu, Christopher Fucile, John J. Treanor, Alexander F. Rosenberg, Martin S. Zand, Michael C. Keefer, Luis Martínez‐Sobrido, James J. Kobie	2018	53
14	Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59 AIDS Research and Human Retroviruses ·Michael C. Keefer, Barney S. Graham, MJ McElrath, Thomas J. Matthews, Donald M. Stablein, Lawrence Corey, Peter F. Wright, Dale N. Lawrence, Patricia Fast, Kent J. Weinhold, Ray‐Hahn Hsieh, David Chernoff, CORRY DEKKER, Raphael Dolin, (unknown)	1996	52
15	High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects The Journal of Infectious Diseases ·Paul A. Goepfert, Helen Horton, M. Juliana McElrath, Sanjay Gurunathan, Guido Ferrari, Georgia D. Tomaras, David C. Montefiori, Mary Allen, Ya‐Lin Chiu, Paul Spearman, Jonathan D. Fuchs, Beryl A. Koblin, William A. Blattner, Sharon E. Frey, Michael C. Keefer, Lindsey R. Baden, Lawrence Corey, (unknown)	2005	49
16	Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial Vaccine ·Paul Spearman, Spyros A. Kalams, Marnie Elizaga, Barbara Metch, Ya-Lin Chiu, Mary Allen, Kent J. Weinhold, Guido Ferrari, Scott Parker, M. Juliana McElrath, Sharon E. Frey, Jonathan D. Fuchs, Michael C. Keefer, Michael D. Lubeck, Michael A. Egan, Ralph P. Braun, John H. Eldridge, Barton F. Haynes, Lawrence Corey	2008	49
17	Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans AIDS Research and Human Retroviruses ·Michael C. Keefer, Barney S. Graham, Robert B. Belshe, David H. Schwartz, Lawrence Corey, Dani P. Bolognesi, Donald M. Stablein, David C. Montefiori, MJ McElrath, M L Clements, Geoffrey J. Gorse, Peter F. Wright, Thomas J. Matthews, Gale Smith, Dale N. Lawrence, Raphael Dolin	1994	46
18	A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection AIDS Research and Human Retroviruses ·M. Juliana McElrath, Lawrence Corey, David C. Montefiori, Mark Wolff, M. Juliana Elrath, Michael C. Keefer, Robert B. Belshe	2000	45
19	Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV‐1 Genes or the Gene for Rabies Virus G Protein The Journal of Infectious Diseases ·Peter F. Wright, Jiří Městecký, M. Juliana McElrath, Michael C. Keefer, Geoffrey J. Gorse, Paul A. Goepfert, Zina Moldoveanu, David H. Schwartz, Paul Spearman, Raphaëlle El Habib, Michele Spring, Yuwei Zhu, Carol Smith, Jorge Flores, Kent J. Weinhold	2004	45
20	Itraconazole Maintenance Treatment for Histoplasmosis in AIDS: A Prospective, Multicenter Trial Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Frederick Hecht, Joseph Wheat, Ann H. Korzun, Richard Hafner, Kenneth J. Skahan, Robert A. Larsen, Maria Theresa Limjoco, Maggie Simpson, Debra Schneider, Michael C. Keefer, Rebecca A. Clark, Kwan Kew Lai, Jeffrey M. Jacobson, Kathleen Squires, John Bartlett, William G. Powderly	1997	44

About Michael C. Keefer

Michael C. Keefer is a scholar working on Virology, Immunology, Infectious Diseases, Epidemiology and Hepatology, having authored 71 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (46 papers), Immune Cell Function and Interaction (21 papers), vaccines and immunoinformatics approaches (15 papers), HIV/AIDS Research and Interventions (14 papers), Immunotherapy and Immune Responses (12 papers), Herpesvirus Infections and Treatments (9 papers), T-cell and B-cell Immunology (8 papers) and HIV/AIDS drug development and treatment (8 papers). The work is most often cited by research in Virology (1.3k citations), Immunology (918 citations), Infectious Diseases (691 citations), Epidemiology (730 citations) and Hepatology (79 citations). Michael C. Keefer has collaborated with scholars based in United States, South Africa and France. Frequent co-authors include David C. Montefiori, Kent J. Weinhold, Barney S. Graham, Lawrence Corey, M. Juliana McElrath, Geoffrey J. Gorse, Mark J. Mulligan, Thomas G. Evans, Patricia Fast and Robert B. Belshe. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, PLoS ONE, AIDS Research and Human Retroviruses and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact